- Home
- CDIO
as 11-14-2024 3:31pm EST
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 12.4M | IPO Year: | N/A |
| Target Price: | $2.00 | AVG Volume (30 days): | 5.4M |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.19 - $3.56 | Next Earning Date: | 11-13-2024 |
| Revenue: | $39,138 | Revenue Growth: | 1363.10% |
| Revenue Growth (this year): | 2093.61% | Revenue Growth (next year): | 43.05% |
Latest Cardio Diagnostics Holdings Inc. Common stock News
CDIO Breaking Stock News: Dive into CDIO Ticker-Specific Updates for Smart Investing
Business Wire
3 days ago
Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference
Business Wire
a month ago
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
ACCESSWIRE
2 months ago
Potential Catalyst Right Around The Corner? CMS To Announce Preliminary Medicare Payment For Cardio Diagnostics' Heart Disease Tests
Business Wire
4 months ago
Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions
Business Wire
5 months ago
Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois
Business Wire
5 months ago
Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum
Business Wire
5 months ago
Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality
Business Wire
6 months ago
Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests
Compare CDIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CDIO Cardio Diagnostics Holdings Inc. Common stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.